Halenda S P, Zavoico G B, Feinstein M B
J Biol Chem. 1985 Oct 15;260(23):12484-91.
Washed human platelets prelabeled with [14C]arachidonic acid and then exposed to the Ca2+ ionophore A23187 mobilized [14C]arachidonic acid from phospholipids and formed 14C-labeled thromboxane B2, 12-hydroxy-5-8,10-heptadecatrienoic acid, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Addition of phorbol myristate acetate (PMA) by itself at concentrations from 10 to 1000 ng/ml did not release arachidonic acid or cause the formation of any of its metabolites, nor did it affect the metabolism of exogenously added arachidonic acid. When 1 microM A23187 was added to platelets pretreated with 100 ng of PMA/ml for 10 min, the release of arachidonic acid, and the amount of all arachidonic acid metabolites formed, were greatly increased (average 4.1 +/- 0.5-fold in eight experiments). This effect of PMA was mimicked by other stimulators of protein kinase C, such as phorbol dibutyrate and oleoyl acetoyl glycerol, but not by 4-alpha-phorbol 12,13-didecanoate, which does not stimulate protein kinase C. However, phosphorylation of the cytosolic 47-kDa protein, the major substrate for protein kinase C in platelets, was produced at lower concentrations of PMA and at a much higher rate than enhancement of arachidonic acid release by PMA, suggesting that 47-kDa protein phosphorylation is not directly involved in mobilization of the fatty acid. PMA also potentiated arachidonic acid release when stimulation of phospholipase C by the ionophore (which is due to thromboxane A2 and/or secreted ADP) was blocked by aspirin plus ADP scavengers, i.e. apyrase or creatine phosphate/creatine phosphokinase. Increased release of arachidonic acid was attributable to loss of [14C]arachidonic acid primarily from phosphatidylcholine (79%) with lesser amounts derived from phosphatidylinositol (12%) and phosphatidylethanolamine (8%). Phosphatidic acid, whose production is a sensitive indicator of phospholipase C activation, was not formed. Thus, the potentiation of arachidonic acid release by PMA appeared to be due to phospholipase A2 activity. These results suggest that diacylglycerol formed in response to stimulation of platelet receptors by agonists may cooperatively promote release of arachidonic acid via a Ca2+/phospholipase A2-dependent pathway.
用[14C]花生四烯酸预先标记的洗涤过的人血小板,然后暴露于钙离子载体A23187,可使花生四烯酸从磷脂中动员出来,并生成14C标记的血栓素B2、12-羟基-5,8,10-十七碳三烯酸和12-羟基-5,8,10,14-二十碳四烯酸。单独添加浓度为10至1000 ng/ml的佛波酯肉豆蔻酸酯(PMA)不会释放花生四烯酸或导致其任何代谢产物的形成,也不会影响外源添加的花生四烯酸的代谢。当将1 microM A23187添加到用100 ng/ml PMA预处理10分钟的血小板中时,花生四烯酸的释放以及所有形成的花生四烯酸代谢产物的量都大大增加(在八个实验中平均增加4.1±0.5倍)。PMA的这种作用可被蛋白激酶C的其他刺激剂(如佛波酯二丁酸酯和油酰乙酰甘油)模拟,但不能被不刺激蛋白激酶C的4-α-佛波醇12,13-十二烷酸酯模拟。然而,血小板中蛋白激酶C的主要底物——胞质47-kDa蛋白的磷酸化,在较低浓度的PMA下就会发生,且速率比PMA增强花生四烯酸释放的速率高得多,这表明47-kDa蛋白的磷酸化并不直接参与脂肪酸的动员。当离子载体(由于血栓素A2和/或分泌的ADP)对磷脂酶C的刺激被阿司匹林加ADP清除剂(即腺苷三磷酸双磷酸酶或磷酸肌酸/磷酸肌酸激酶)阻断时,PMA也能增强花生四烯酸的释放。花生四烯酸释放的增加主要归因于[14C]花生四烯酸主要从磷脂酰胆碱(79%)中丢失,较少部分来自磷脂酰肌醇(12%)和磷脂酰乙醇胺(8%)。没有形成作为磷脂酶C活化敏感指标的磷脂酸。因此,PMA增强花生四烯酸释放似乎是由于磷脂酶A2的活性。这些结果表明,由激动剂刺激血小板受体而形成的二酰基甘油可能通过Ca2+/磷脂酶A2依赖性途径协同促进花生四烯酸的释放。